Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial.
Br J Cancer
; 121(4): 312-317, 2019 08.
Article
in En
| MEDLINE
| ID: mdl-31296923
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoembryonic Antigen
/
Colonic Neoplasms
/
Oxaliplatin
/
Antineoplastic Agents
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Br J Cancer
Year:
2019
Document type:
Article
Affiliation country: